Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 71

1.

DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study.

Liu XP, Yin XH, Meng XY, Yan XH, Cao Y, Zeng XT, Wang XH.

Medicine (Baltimore). 2018 Sep;97(39):e11830. doi: 10.1097/MD.0000000000011830.

2.

Desmosterolosis presenting with multiple congenital anomalies.

Rohanizadegan M, Sacharow S.

Eur J Med Genet. 2018 Mar;61(3):152-156. doi: 10.1016/j.ejmg.2017.11.009. Epub 2017 Nov 23.

3.

Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma.

Dai M, Zhu XL, Liu F, Xu QY, Ge QL, Jiang SH, Yang XM, Li J, Wang YH, Wu QK, Ai ZH, Teng YC, Zhang ZG.

Sci Rep. 2017 Jan 23;7:41404. doi: 10.1038/srep41404.

4.
5.

Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.

Ezzikouri S, Kimura K, Sunagozaka H, Kaneko S, Inoue K, Nishimura T, Hishima T, Kohara M, Tsukiyama-Kohara K.

EBioMedicine. 2015 Apr 13;2(6):604-12. doi: 10.1016/j.ebiom.2015.04.007. eCollection 2015 Jun.

6.

DHCR24 is an independent predictor of progression in patients with non-muscle-invasive urothelial carcinoma, and its functional role is involved in the aggressive properties of urothelial carcinoma cells.

Lee GT, Ha YS, Jung YS, Moon SK, Kang HW, Lee OJ, Joung JY, Choi YH, Yun SJ, Kim WJ, Kim IY.

Ann Surg Oncol. 2014 Dec;21 Suppl 4:S538-45. doi: 10.1245/s10434-014-3560-6. Epub 2014 Feb 22.

PMID:
24562935
7.

3 β-hydroxysteroid-Δ 24 reductase (DHCR24) protects neuronal cells from apoptotic cell death induced by endoplasmic reticulum (ER) stress.

Lu X, Li Y, Wang W, Chen S, Liu T, Jia D, Quan X, Sun D, Chang AK, Gao B.

PLoS One. 2014 Jan 29;9(1):e86753. doi: 10.1371/journal.pone.0086753. eCollection 2014.

8.

Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis.

Luu W, Zerenturk EJ, Kristiana I, Bucknall MP, Sharpe LJ, Brown AJ.

J Lipid Res. 2014 Mar;55(3):410-20. doi: 10.1194/jlr.M043257. Epub 2013 Dec 20.

9.

Promoter analysis of the DHCR24 (3β-hydroxysterol Δ(24)-reductase) gene: characterization of SREBP (sterol-regulatory-element-binding protein)-mediated activation.

Daimiel LA, Fernández-Suárez ME, Rodríguez-Acebes S, Crespo L, Lasunción MA, Gómez-Coronado D, Martínez-Botas J.

Biosci Rep. 2012 Dec 6;33(1):57-69. doi: 10.1042/BSR20120095.

10.

Gender dependent effect of DHCR24 polymorphism on the risk for Alzheimer's disease.

Fehér A, Juhász A, Pákáski M, Kálmán J, Janka Z.

Neurosci Lett. 2012 Sep 20;526(1):20-3. doi: 10.1016/j.neulet.2012.08.010. Epub 2012 Aug 14.

PMID:
22910610
11.

The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1).

Zerenturk EJ, Kristiana I, Gill S, Brown AJ.

Biochim Biophys Acta. 2012 Sep;1821(9):1269-77. doi: 10.1016/j.bbalip.2011.11.009. Epub 2011 Dec 10.

PMID:
22178193
12.

The membrane topological analysis of 3β-hydroxysteroid-Delta24 reductase (DHCR24) on endoplasmic reticulum.

Lu X, Li Y, Liu J, Cao X, Wang X, Wang D, Seo H, Gao B.

J Mol Endocrinol. 2012 Jan 25;48(1):1-9. doi: 10.1530/JME-11-0132. Print 2012 Feb.

PMID:
22010141
13.

Simvastatin modulates the Alzheimer's disease-related gene seladin-1.

Ramos MC, Sierra S, Ramirez C, Velasco J, Burgos JS.

J Alzheimers Dis. 2012;28(2):297-301. doi: 10.3233/JAD-2011-111118.

PMID:
21987590
14.

Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.

Swaminathan S, Shen L, Risacher SL, Yoder KK, West JD, Kim S, Nho K, Foroud T, Inlow M, Potkin SG, Huentelman MJ, Craig DW, Jagust WJ, Koeppe RA, Mathis CA, Jack CR Jr, Weiner MW, Saykin AJ; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Mar;6(1):1-15. doi: 10.1007/s11682-011-9136-1.

15.

The desmosterolosis phenotype: spasticity, microcephaly and micrognathia with agenesis of corpus callosum and loss of white matter.

Zolotushko J, Flusser H, Markus B, Shelef I, Langer Y, Heverin M, Björkhem I, Sivan S, Birk OS.

Eur J Hum Genet. 2011 Sep;19(9):942-6. doi: 10.1038/ejhg.2011.74. Epub 2011 May 11.

16.

Identification and analysis of the promoter region of the human DHCR24 gene: involvement of DNA methylation and histone acetylation.

Drzewinska J, Walczak-Drzewiecka A, Ratajewski M.

Mol Biol Rep. 2011 Feb;38(2):1091-101. doi: 10.1007/s11033-010-0206-z. Epub 2010 Jun 22.

PMID:
20568014
17.

Seladin-1 expression is regulated by promoter methylation in adrenal cancer.

Simi L, Malentacchi F, Luciani P, Gelmini S, Deledda C, Arvia R, Mannelli M, Peri A, Orlando C.

BMC Cancer. 2010 May 13;10:201. doi: 10.1186/1471-2407-10-201.

18.

Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancer.

Battista MC, Guimond MO, Roberge C, Doueik AA, Fazli L, Gleave M, Sabbagh R, Gallo-Payet N.

Prostate. 2010 Jun 15;70(9):921-33. doi: 10.1002/pros.21126.

PMID:
20166102
19.

Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells.

McGrath KC, Li XH, Puranik R, Liong EC, Tan JT, Dy VM, DiBartolo BA, Barter PJ, Rye KA, Heather AK.

Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):877-82. doi: 10.1161/ATVBAHA.109.184663. Epub 2009 Mar 26.

PMID:
19325144
20.

The selective Alzheimer's disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor target gene.

Wang Y, Rogers PM, Stayrook KR, Su C, Varga G, Shen Q, Nagpal S, Burris TP.

Mol Pharmacol. 2008 Dec;74(6):1716-21. doi: 10.1124/mol.108.048538. Epub 2008 Sep 24.

Supplemental Content

Support Center